Last $64.68 USD
Change Today +1.58 / 2.50%
Volume 3.5M
As of 8:04 PM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

eli lilly & co (LLY) Snapshot

Open
$63.41
Previous Close
$63.10
Day High
$64.75
Day Low
$63.41
52 Week High
09/19/14 - $67.14
52 Week Low
12/17/13 - $48.88
Market Cap
72.3B
Average Volume 10 Days
4.5M
EPS TTM
$3.16
Shares Outstanding
1.1B
EX-Date
11/12/14
P/E TM
20.5x
Dividend
$1.96
Dividend Yield
3.03%
Current Stock Chart for ELI LILLY & CO (LLY)

eli lilly & co (LLY) Details

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health Products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men at high risk of fracture; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency, as well as provides anti-infectives. Its neuroscience products treat major depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; attention-deficit hyperactivity disorder; depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and brain imaging of beta-amyloid neuritic plaques. The company’s oncology products treat pancreatic, metastatic breast, non-small cell lung, ovarian, bladder, colorectal, and head and neck cancers, as well as malignant pleural mesothelioma; and cardiovascular products are used to treat erectile dysfunction and benign prostatic hyperplasia, and pulmonary arterial hypertension, as well as to reduce thrombotic cardiovascular events and as adjunct to percutaneous coronary intervention. In addition, it provides animal health products, such as cattle feed additives; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to enhance milk productivity in dairy cows; anticoccidial agents; and products that prevent flea infestations on dogs, kills fleas, prevent heartworm disease, and control intestinal parasite infections. The company distributes its products through independent wholesale distributors and directly to pharmacies. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

37,925 Employees
Last Reported Date: 02/19/14
Founded in 1876

eli lilly & co (LLY) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $1.5M
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $1.0M
Executive Vice President of Science & Technol...
Total Annual Compensation: $1.0M
Senior Vice President and President of Lilly ...
Total Annual Compensation: $680.7K
Senior Vice President and General Counsel
Total Annual Compensation: $765.0K
Compensation as of Fiscal Year 2013.

eli lilly & co (LLY) Key Developments

Eli Lilly and Company Declares Fourth-Quarter 2014 Dividend Payable on December 10, 2014

The board of directors of Eli Lilly and Company has declared a dividend for the fourth quarter of 2014 of $0.49 per share on outstanding common stock. The dividend is payable on December 10, 2014 to shareholders of record at the close of business on November 14, 2014.

Eli Lilly and Company to Close its Guayama Facility

Eli Lilly and Company announced that it is closing its Guayama facility because the patents on some of the drugs made there have expired. That means new competition reached the market and its sales and prices dropped. The company intends to sell the Guayama plant. Lilly said the 100 employees who work there will be offered jobs at another one of its facilities on the island, which are located in Carolina, Puerto Rico. Guayama is in the southeastern part of Puerto Rico, and Carolina is in the northeast.

Eli Lilly Seeks To Sell Guayama Plant.

Eli Lilly and Company (NYSE:LLY) plans to conclude production and pursue a sale of one of its three manufacturing plants in Puerto Rico. Eli Lilly intends to sell the Guayama plant. Lilley shares slipped 1.3% to $62.06.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:US $64.68 USD +1.58

LLY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $42.39 USD +0.93
AbbVie Inc $56.29 USD +1.88
Amgen Inc $144.09 USD +6.58
AstraZeneca PLC 4,236 GBp +66.00
Teva Pharmaceutical Industries Ltd $53.26 USD +1.57
View Industry Companies
 

Industry Analysis

LLY

Industry Average

Valuation LLY Industry Range
Price/Earnings 20.1x
Price/Sales 3.2x
Price/Book 3.8x
Price/Cash Flow 20.8x
TEV/Sales 2.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit www.lilly.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.